Harshvardhan P, Anuradha N. Comparative analysis of fructosamine and HbA1c as a glycemic control marker in Type 2 diabetes patients in a tertiary care hospital study. Asian Journal of Medical Sciences. 2023;14(10):73-78.

Krishnaveni S, Sirivelu B, Sucheta YBD, Veeranna B. Association of fructosamine, glycated albumin and hba1c in prediabetes, diabetic and associated complications. International journal of health sciences. 2022;6(S7):4693-4699.

Vasileva B, Gatev E, Aleksandrov A, Kerezieva S, Ilieva S, Popova D, et al. Serum Fructosamine as a Marker for Glycemic Control in Patients with Diabetic Nephropathy. Proceedings of the Bulgarian Academy of Sciences. 2024;77(3):442–450.

Cefalu WT, Parker TB, Johnson CR. Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients. Diabetes Care.1988;11(8):662-4.

Goyal J, Das N, Kumar N, Raghav MS, Bhatia PS, Singh KP, et al. Comparative evaluation of fructosamine and HbA1c as a marker of glycemic control in Type 2 diabetes: A hospital based study. Int J Health Sci Res. 2019;9(9):269-274.

Chandran K, Lee SM, Shen L, Tng EL. Fructosamine and HbA1c: A Correlational Study in a Southeast Asian Population. J ASEAN Fed Endocr Soc. 2024;39(1):26-30.

Baker JR, Metcalf PA, Johnson RN, Newman D, Rietz P. Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem. 1985;31(9):1550-4.